Influence of Food on the Bioavailability of Two Doses of Telmisartan/HCTZ Fixed-dose Combination in Japanese Healthy Male Volunteers
NCT02276378 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 32
Last updated 2014-10-28
Summary
To investigate the relative bioavailability and pharmacokinetics of the fixed-dose combination tablets (telmisartan 40 mg/HCTZ 12.5 mg and telmisartan 80 mg/HCTZ 12.5 mg) after food intake in comparison with those in the fasting state in healthy Japanese male volunteers
Conditions
- Healthy
Interventions
- DRUG
-
Telmisartan low
- DRUG
-
Telmisartan high
- DRUG
-
Hydrochlorothiazide (HCTZ)
- OTHER
-
Japanese meal
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 20 Years
- Max Age
- 35 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2008-07-31
- Primary Completion
- 2008-08-31
More Related Trials
-
Bioavailability Study of Torsemide Tablets Under Fed Conditions
NCT00654043 ·Status: COMPLETED ·Phase: PHASE1
-
Bioavailability Study of Torsemide Tablets Under Fasting Conditions
NCT00653549 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence of Telmisartan / Ramipril Fixed Dose Combination Compared With the Monocomponents Given Concomitantly to Healthy Male and Female Volunteers
NCT02214979 ·Status: COMPLETED ·Phase: PHASE1
-
A Bioequivalence Study of Two Different Formulations of Olmesartan Medoxomil/ Hydrochlorothiazide After a Single Oral Dose Administration Under Fasting Conditions
NCT04138888 ·Status: UNKNOWN ·Phase: PHASE1
-
Bioavailability of Lacidipine and Telmisartan Fixed Dose Combination Tablets Relative to Separate Tablets in Healthy Subjects
NCT02209649 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalency Study of Losartan Potassium/Hydrochlorothiazide 100 mg/25 mg Tablet Under Fasted Conditions
NCT01102478 ·Status: COMPLETED ·Phase: NA
-
Bioequivalence Study of Losartan Potassium and Hydrochlorothiazide (100 mg / 25 mg Tablet) [Test Formulation, Torrent Pharmaceuticals Ltd., India] Versus Hyzaar® (100 mg / 25 mg Tablet) [Reference Formulation, Merck & Co., Inc., USA] in Healthy Human Volunteers Under Fasting Conditions.
NCT01218711 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence Study of Two Formulations of Telmisartan 80 mg Tablets in Healthy Adult Volunteers Under Fasting State
NCT03705533 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence Study of Losartan Potassium and Hydrochlorothiazide (100 mg / 25 mg Tablet) [Test Formulation, Torrent Pharmaceuticals Ltd., India] Versus Hyzaar® (100 mg / 25 mg Tablet) [Reference Formulation, Merck & Co., Inc., USA] in Healthy Human Volunteers Under Fed Conditions
NCT01218724 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Slow Release Hydrocortisone on Fed & Fasting Volunteers; Immediate Release on Fasting Only
NCT02408068 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalency Study of Torsemide Tablets Under Fasting Conditions
NCT00602303 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Effect of Food or no Food on the Bioavailability of an Extended Release (ER) Torsemide and Spironolactone Fixed Dose Combination (FDC) Tablet in Healthy Adult Subjects
NCT07043634 ·Status: COMPLETED ·Phase: PHASE3
-
Bioequivalence Study of Lisinopril and Hydrochlorothiazide Tablets (20+25) mg Under Fasting Conditions
NCT01831700 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence Study of Lisinopril and Hydrochlorothiazide Tablets (20+25) mg Under Fed Conditions
NCT01827878 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions
NCT02962323 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy People to Compare 2 Different Formulations of Nerandomilast Tablets When Taken With or Without Food
NCT06624072 ·Status: COMPLETED ·Phase: PHASE1
-
Bio Equivalence Study of Torrent Pharmaceutical Ltd's Rosuvastatin Calcium Tablets Under Fasting Condition.
NCT02962310 ·Status: COMPLETED ·Phase: PHASE1
-
Losartan Potassium/Hydrochlorothiazide 100/25 mg Tablets in Healthy Subjects Under Non-Fasting Conditions
NCT01149473 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Estimate the Relative Bioavailability Compared to Commercial Extended-release Tablet Formulation and the Effects of Food Or Sprinkling on Applesauce for Fesoterodine Sustained-release Beads-in-capsule Formulations in Healthy Adult Volunteers
NCT02160158 ·Status: COMPLETED ·Phase: PHASE1
-
Crossover Bioequivalence Study of Irbesartan HCTZ 300/25 mg Tablets Under Fasted Conditions
NCT01712139 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015 and Co-administration of BR1015-1 and BR1015-2 Under Fasting Conditions
NCT06744127 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence of Telmisartan/g Ramipril Fixed Dose Combination Compared With the Monocomponents Telmisartan and Ramipril (Two Different Formulations) Given Concomitantly to Healthy Male and Female Volunteers
NCT02214992 ·Status: COMPLETED ·Phase: PHASE1
-
A Trial to Characterize Differences in Blood Levels of Different Lots of Centanafadine QD XR and to Understand the Effect of Food on Blood Levels
NCT07253441 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalency Study of Losartan Potassium/Hydrochlorothiazide 100 mg /25 mg Tablet Under Fed Conditions
NCT01102465 ·Status: COMPLETED ·Phase: NA
-
Comparison of Blood Levels of HTL0016878 From an Oral Capsule and an Oral Solution
NCT04935320 ·Status: COMPLETED ·Phase: PHASE1